Enzo Biochem

Enzo Biochem Earnings Yield

Delisted

The Earnings Yield of Enzo Biochem (ENZ) as of Nov 12, 2026 is -22.65 %. In the previous year, Earnings Yield was -71.17 % — a change of -68.17% (higher).

Earnings Yield

-22.65 %

YoY

-68.17%

Last updated:

Earnings Yield of Enzo Biochem is 2024 -22.65 % . Earnings Yield of Enzo Biochem was 2023 -71.17 % . It decreases by -68.17% higher compared to the previous year.

The Enzo Biochem Earnings Yield history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Earnings Yield
Date
Earnings Yield
Jan 1, 2017
-28.11 USD
Jan 1, 2018
6.82 USD
Jan 1, 2019
-77.78 USD
Jan 1, 2020
21.49 USD
Jan 1, 2021
-49.84 USD
Jan 1, 2022
-30.02 USD
Jan 1, 2023
-71.17 USD
Jan 1, 2024
-22.65 USD
The Enzo Biochem Earnings Yield history
YEAREarnings YieldYoY
-22.65 %-68.17%
-71.17 %+137.07%
-30.02 %-39.76%
-49.84 %-331.89%
21.49 %-127.63%
-77.78 %-1,240.00%
6.82 %-124.27%
-28.11 %+312.00%
-6.82 %-105.52%
123.64 %-2,069.57%
-6.28 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Enzo Biochem Stock analysis

What does Enzo Biochem do? Enzo Biochem Inc is a US-based company operating in the biotechnology sector. It was founded in 1976 by Elazar Rabbani and is headquartered in New York. The company focuses on developing, producing, and marketing innovative diagnostic and therapeutic products for the medical industry. Enzo Biochem Inc's business model is based on the application of modern technologies for the development and synthesis of molecules for medical technology and life sciences. At the same time, the company also offers diagnostic testing systems and clinical laboratory services to its customers. Enzo Biochem's business model is therefore diverse and covers various areas. Enzo Biochem divides its business into three main segments: life sciences, clinical labs, and therapeutics. In the life sciences segment, the company engages in research and development of technologies for synthesizing molecules for medical technology. In the clinical labs segment, Enzo Biochem offers diagnostic testing systems and clinical laboratory services for use in medical diagnostics. The therapeutics segment manufactures therapeutic products for the treatment of viral infections. Enzo Biochem's product offering includes a wide range of products and services. This includes molecules for medical technology, diagnostic testing systems, and therapy products for viral infections. The product lines of Enzo Biochem include: - Molecules for medical technology: Enzo Biochem has developed a wide range of molecules for medical technology and is a leader in this field. These molecules include proteins, antibodies, and other biomolecules. The company also offers custom molecules for specific applications. - Diagnostic testing systems: The company offers a wide range of diagnostic testing systems tailored to the needs of laboratories and clinics. The tests include tests for infectious diseases, cancer, metabolic disorders, and other diseases. - Clinical laboratory services: Enzo Biochem provides a wide range of clinical laboratory services, including blood tests, microbiological tests, urine, stool, and body fluid tests, as well as histological analysis of tissue samples. - Therapy products: Enzo Biochem has developed a broad portfolio of therapy products for the treatment of viral infections. These products include immunomodulators, antivirals, and other therapeutics aimed at combating various pathogens. Enzo Biochem has made a name for itself in the biotechnology industry through continuous innovation and high-quality products. The company has also engaged in partnerships, acquisitions, and joint ventures to expand its global footprint. It has a global presence and works with leading pharmaceutical and biotech companies from around the world. Overall, Enzo Biochem has established itself as a leading biotechnology company operating in the fields of life sciences, clinical labs, and therapeutics. The company offers a wide range of products and services tailored to the needs of laboratories and clinics. Enzo Biochem has established itself as an innovation leader in the biotechnology industry and is committed to further expanding its business through the development of new products and technologies. Enzo Biochem is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Enzo Biochem stock

Earnings Yield of Enzo Biochem is -22.65 % in 2024.

Earnings Yield of Enzo Biochem changed from -71.17 % to -22.65 %, representing a -68.17% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Earnings Yield Enzo Biochem since 2006 – with annual values, charts, and detailed analysis.

Earnings Yield is the inverse of the P/E ratio. It shows the percentage of each dollar invested that was earned by the company. Higher earnings yield indicates better value.

To evaluate Earnings Yield's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Earnings Yield.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Earnings Yield's Enzo Biochem with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Enzo Biochem

All Key Metrics — Enzo Biochem